222 related articles for article (PubMed ID: 28673836)
1. Microneedles enhance topical delivery of 15-deoxy-Δ
Macedo CG; Jain AK; Franz-Montan M; Napimoga MH; Clemente-Napimoga JT; Gill HS
J Control Release; 2017 Nov; 265():22-29. PubMed ID: 28673836
[TBL] [Abstract][Full Text] [Related]
2. Poloxamer micellar system for intra-articular injection of 15-deoxy-
Abdalla HB; Napimoga MH; Macedo CG; Bonfante R; De Araujo DR; de Mello NFS; Carvalho LB; Fraceto LF; Clemente-Napimoga JT
Int J Pharm; 2020 Jun; 583():119383. PubMed ID: 32360545
[TBL] [Abstract][Full Text] [Related]
3. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
4. 15-deoxy-Δ12,14-prostaglandin J2 reduces albumin-induced arthritis in temporomandibular joint of rats.
Silva Quinteiro M; Henrique Napimoga M; Gomes Macedo C; Furtado Freitas F; Balassini Abdalla H; Bonfante R; Trindade Clemente-Napimoga J
Eur J Pharmacol; 2014 Oct; 740():58-65. PubMed ID: 25016088
[TBL] [Abstract][Full Text] [Related]
5. 15d-PGJ2-loaded in nanocapsules enhance the antinociceptive properties into rat temporomandibular hypernociception.
Clemente-Napimoga JT; Moreira JA; Grillo R; de Melo NF; Fraceto LF; Napimoga MH
Life Sci; 2012 Jun; 90(23-24):944-9. PubMed ID: 22564409
[TBL] [Abstract][Full Text] [Related]
6. The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats.
Quinteiro MS; Napimoga MH; Mesquita KP; Clemente-Napimoga JT
Eur J Pain; 2012 Sep; 16(8):1106-15. PubMed ID: 22354681
[TBL] [Abstract][Full Text] [Related]
7. The role of endogenous opioid peptides in the antinociceptive effect of 15-deoxy(Δ12,14)-prostaglandin J2 in the temporomandibular joint.
Macedo CG; Napimoga MH; Rocha-Neto LM; Abdalla HB; Clemente-Napimoga JT
Prostaglandins Leukot Essent Fatty Acids; 2016 Jul; 110():27-34. PubMed ID: 27255640
[TBL] [Abstract][Full Text] [Related]
8. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
[TBL] [Abstract][Full Text] [Related]
9. Microneedles Coated with Tramadol Exhibit Antinociceptive Effect in a Rat Model of Temporomandibular Hypernociception.
Abdalla HB; Jain AK; Napimoga MH; Clemente-Napimoga JT; Gill HS
J Pharmacol Exp Ther; 2019 Sep; 370(3):834-842. PubMed ID: 30872390
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of propranolol in the temporomandibular joint of female rats and its contribution to antinociceptive action.
Zanelatto FB; Dias EV; Teixeira JM; Sartori CR; Parada CA; Tambeli CH
Eur J Pain; 2018 Mar; 22(3):572-582. PubMed ID: 29226500
[TBL] [Abstract][Full Text] [Related]
11. 15-Deoxy-Δ
Takagi T; Naito Y; Mizushima K; Hirai Y; Kamada K; Uchiyama K; Handa O; Ishikawa T; Itoh Y
Arch Biochem Biophys; 2019 Nov; 677():108183. PubMed ID: 31704099
[TBL] [Abstract][Full Text] [Related]
12. Role of central opioid on the antinociceptive effect of sulfated polysaccharide from the red seaweed Solieria filiformis in induced temporomandibular joint pain.
Araújo IW; Chaves HV; Pachêco JM; Val DR; Vieira LV; Santos R; Freitas RS; Rivanor RL; Monteiro VS; Clemente-Napimoga JT; Bezerra MM; Benevides NM
Int Immunopharmacol; 2017 Mar; 44():160-167. PubMed ID: 28107753
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception.
Weng Y; Batista-Schepman PA; Barabas ME; Harris EQ; Dinsmore TB; Kossyreva EA; Foshage AM; Wang MH; Schwab MJ; Wang VM; Stucky CL; Story GM
Mol Pain; 2012 Sep; 8():75. PubMed ID: 23013719
[TBL] [Abstract][Full Text] [Related]
14. 15d-PGJ2-Loaded Solid Lipid Nanoparticles: Physicochemical Characterization and Evaluation of Pharmacological Effects on Inflammation.
de Melo NF; de Macedo CG; Bonfante R; Abdalla HB; da Silva CM; Pasquoto T; de Lima R; Fraceto LF; Clemente-Napimoga JT; Napimoga MH
PLoS One; 2016; 11(8):e0161796. PubMed ID: 27575486
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of 15-deoxy-Δ(12,14) -prostaglandin J2 in the development of leptin resistance.
Hosoi T; Matsuzaki S; Miyahara T; Shimizu K; Hasegawa Y; Ozawa K
J Neurochem; 2015 May; 133(3):343-51. PubMed ID: 25662180
[TBL] [Abstract][Full Text] [Related]
16. 15-Deoxy-Δ
Kim W; Lee HN; Jang JH; Kim SH; Lee YH; Hahn YI; Ngo HK; Choi Y; Joe Y; Chung HT; Chen Y; Cha YN; Surh YJ
Antioxid Redox Signal; 2017 Dec; 27(17):1412-1431. PubMed ID: 28398824
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Treatment of Arthritic Mice with 15-Deoxy Δ
Carregaro V; Napimoga MH; Peres RS; Benevides L; Sacramento LA; Pinto LG; Grespan R; Cunha TM; da Silva JS; Cunha FQ
Mediators Inflamm; 2016; 2016():9626427. PubMed ID: 27872515
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-△
Kim W; Jang JH; Zhong X; Seo H; Surh YJ
Front Immunol; 2021; 12():615803. PubMed ID: 33633749
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ ameliorates endotoxin-induced acute lung injury in rats.
Liu D; Geng Z; Zhu W; Wang H; Chen Y; Liang J
Chin Med J (Engl); 2014; 127(5):815-20. PubMed ID: 24571868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
